BERLDRG.BO stock led today’s small-cap winners on the BSE, closing at INR 21.68 after a +28.51% gain on 05 Mar 2026. The spike followed heavy intraday buying that lifted the high to INR 21.96 from an open of INR 18.73. Volume remained modest at 1,242.00 shares, but the surge pushed price above the 200-day average near INR 21.90. Traders should note the move’s technical intensity and low free-float when sizing positions.

BERLDRG.BO stock: market move and immediate drivers

Beryl Drugs Limited (BERLDRG.BO) closed the session at INR 21.68, up INR 4.81 from the previous close of INR 16.87. The one-day percentage gain of 28.51% was the largest intraday increase this week for the company on the BSE in India. The run higher came with a day range of INR 18.73–21.96, suggesting aggressive late buyers pushing price near session highs.

Company-specific newsflow was light. The move looks driven by technical short-covering and a sector-rotation into selective healthcare names. Investors tracking BERLDRG.BO stock should watch for follow-through volume above the 50-day average 3,253.00 shares as confirmation of sustained demand.

Technical snapshot for BERLDRG.BO stock

Technically, BERLDRG.BO stock shows oversold readings before today’s bounce. The RSI sat at 22.15, and the MACD histogram was negative. The strong ADX at 39.50 points to a powerful trend shift. Bollinger bands (Lower INR 19.15, Middle INR 21.48, Upper INR 23.80) tightened before the move, then expanded on the upside.

Short-term traders can use INR 19.00 as initial support and INR 23.80 as first resistance. The stock’s relative volume now sits at 3.81, indicating higher-than-normal trading activity despite low absolute volume. Use tight risk control given the stock’s volatility.

Fundamentals and valuation: BERLDRG.BO stock review

Beryl Drugs operates in Healthcare, focused on bulk drugs and small-volume injectables. The company reports EPS INR 0.03 and a high reported PE near 620.67, reflecting very low trailing earnings relative to price. Book value per share stands at INR 18.67, and price-to-book is about 0.99, suggesting market price near book value.

Key balance metrics include a current ratio of 1.40 and debt-to-equity of 0.45. Enterprise value to EBITDA is 8.66, and cash per share is INR 0.25. These mixed fundamentals imply valuation is sensitive to small earnings swings, which increases event risk for holders of BERLDRG.BO stock.

Meyka AI rates BERLDRG.BO with a score out of 100 and forecast

Meyka AI rates BERLDRG.BO with a score of 63.87 out of 100 | Grade: B | Suggestion: HOLD. This grade factors S&P 500 and sector comparisons, industry peers, financial growth, key metrics, forecasts, and analyst consensus.

Meyka AI’s forecast model projects a yearly level of INR 10.37 and a monthly level of INR 17.92. Compared with today’s INR 21.68, the yearly projection implies an approximate -52.14% downside. Forecasts are model-based projections and not guarantees. Investors should treat these figures as scenario inputs for risk management rather than firm targets.

Analyst signals, ratings and price targets for BERLDRG.BO stock

Public rating data shows conservative outlooks: a recent snapshot lists a company rating of D+ with a recommendation of Strong Sell on objective DCF and profitability metrics. No consensus price target is available. Market-watchers should weigh the mismatch between short-term technical strength and weak rating scores.

Realistic near-term price targets for traders: conservative upside to INR 24.00 if momentum continues, neutral range INR 19.00–22.50, and downside risk to INR 15.92 (52-week low) on negative catalysts.

Trading strategy, sector context and risks for BERLDRG.BO stock

Within the Healthcare sector, stocks can move independently on small-cap flows. BERLDRG.BO stock’s volume profile and low market cap (INR 94,435,054.00) make it sensitive to large orders and volatility. Use position sizes under 1% of portfolio for speculative trades and set stop losses near INR 19.00.

Primary risks include earnings volatility (EPS INR 0.03), thin liquidity (avg volume 3,253.00), and high PE distortions. Opportunities arise from short-term technical rebounds and any contract or product wins. For background, see the company site Beryl Drugs Ltd and financial snapshot FinancialModelingPrep image. Also see our platform page for live tracking: Meyka stock page.

Final Thoughts

BERLDRG.BO stock delivered a sharp one-day gain, closing at INR 21.68 on the BSE on 05 Mar 2026. The move appears driven by technical buying rather than new fundamental catalysts. Short-term traders can exploit momentum with tight stops and an initial upside target near INR 24.00, while longer-term investors should watch earnings trends and liquidity. Meyka AI’s forecast model projects a yearly level of INR 10.37, which implies sizeable downside versus the current price. That forecast highlights valuation risk for buy-and-hold investors. Use this outlook with position-level risk limits. Meyka AI, our AI-powered market analysis platform, provides these data-driven signals to inform trade sizing and scenario planning. Forecasts are model-based projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.